The Company is a Korea-based company mainly engages in the development and manufacture of pharmaceuticals. The Company mainly develops and produces pharmaceuticals including epilepsy drugs, sleep disorder drugs, rare neurological disorder drugs, concentration disorder drugs, schizophrenia drugs, and bipolar disorder drugs, among others. The Company also engages in the new drug development business. The Company was founded on April1 , 2011 and its shares are listed on Korea Stock Exchaneg on July 2, 2020.
Headquarters
221, Pangyoyeok-Ro, Bundang-Gu
Seongnam; Gyeonggi;
Contact Details: Purchase the Sk Biopharmaceuticals Co.,Ltd. (Seongnam) report to view the information.
Website: http://www.skbp.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service